Ovarian cancer
Kolstad, P.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 93(26): 1962-1965
1973
ISSN/ISBN: 0029-2001 PMID: 4767938 Document Number: 68448
Document emailed within 1 workday
Related Documents
Fukuyama, A.; Yokoyama, Y.; Wada, J.; Hashimoto, T.; Oda, T.; Sato, S.; Mizunuma, H. 2009: Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer European Journal of Gynaecological Oncology 30(2): 208-210Hartge, P.; Hayes, R.; Reding, D.; Sherman, M.E.; Prorok, P.; Schiffman, M.; Buys, S. 2000: Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial American Journal of Obstetrics and Gynecology 183(5): 1232-1237
Suzuki, M.; Sekiguchi, I.; Tamada, T.; Sakurabayashi, I.; Kawai, T. 1985: Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors Rinsho Byori. Japanese Journal of Clinical Pathology 33(2): 173-177
Rose, P.G.; Hunter, R.E. 1994: Advanced ovarian cancer in a woman with a family history of ovarian cancer, discovered at referral for prophylactic oophorectomy. A case report Journal of Reproductive Medicine 39(11): 908-910
Tanaka, K. 1989: Ovarian cancer--assessment of methods for cytogenetic analysis and chromosome aberrations found in ovarian cancer Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 80: 268-280
Du Bois, A.; Lück, H.J.; Meier, W.; Möbus, V.; Costa, S.; Richter, B.; Warm, M.; Bauknecht, T.; Schröder, W.; Olbricht, S.; Nitz, U.; Jackisch, C. 1997: Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase IIi trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group Seminars in Oncology 24(5 Suppl 15: S15
Chou, Y-Ching.; Chen, Y-Jen.; Lai, C-Ru.; Wang, P-Hui.; Hsin-Chan; Yuan, C-Chung. 2006: Cyclooxygenase-2 expression is higher in ovarian cancer tissue adjacent to endometriosis than in ovarian cancer without comorbid endometriosis European Journal of Obstetrics Gynecology and Reproductive Biology 124(1): 101-105
Ivanov, S.; Batashki, I. 2008: Five years survival in patients with endometrioid ovarian cancer versus patients with serous ovarian cancer Akusherstvo i Ginekologiia 47(5): 9-11
Murakami, F.; Kiyozuka, Y.; Nishimura, H.; Imamura, K.; Yakushiji, M.; Noda, T.; Adachi, S.; Ito, K.; Tamori, N.; Shintani, M. 1993: Etoposide/cis-platinum (CDDP) combined chemotherapy for ovarian cancer: evaluation of optimum schedule for CDDP administration in chronic continuous exposure of ovarian cancer cells to low-dose etoposide in vitro Nihon Sanka Fujinka Gakkai Zasshi 45(2): 125-132
Milsom, I.; Odlind, V. 2008: Oral contraceptives give long-lasting protection against ovarian cancer. use of oral contraceptives can explain reduced incidence of ovarian cancer in Sweden Lakartidningen 105(10): 715-716
Rohde, E.; Reincke, I.; Barten, M. 1986: Ovarian metastasis of cancer of the small intestine with simultaneous ovarian pregnancy Zentralblatt für Gynakologie 108(19): 1184-1188
Ishii, K.; Aoki, Y.; Takakuwa, K.; Tanaka, K. 2001: Ovarian function after radical hysterectomy with ovarian preservation for cervical cancer Journal of Reproductive Medicine 46(4): 347-352
Jin, Z.; Gu, J.; Xin, X.; Li, Y.; Wang, H. 2014: Expression of hexokinase 2 in epithelial ovarian tumors and its clinical significance in serous ovarian cancer European Journal of Gynaecological Oncology 35(5): 519-524
Kawai, S.; Nishida, Y.; Nakada, M.; Tachikawa, M.; Miyagoshi, E. 1985: Standards of nursing of patients with ovarian and uterine cancer--through the nursing actions toward patients with cervical and ovarian cancer scheduled for total hysterectomy Nursing Technique 31(8): 1017-1024
Kariwiga, G.; Amoa, A.B.; Mola, G.; Heywood, S. 1997: Familial ovarian cancer: report of ovarian carcinoma in three sisters Papua and new Guinea Medical Journal 40(3-4): 146-149
Kariwiga, G.; Amoa, A.B.; Mola, G.; Heywood, S. 1997: Familial ovarian cancer: report of ovarian carcinoma in three sisters Papua and new Guinea Medical Journal 40(3-4): 146-149
Jacobs, I.J.; Smith, S.A.; Wiseman, R.W.; Futreal, P.A.; Harrington, T.; Osborne, R.J.; Leech, V.; Molyneux, A.; Berchuck, A.; Ponder, B.A. 1993: A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus Cancer Research 53(6): 1218-1221
Penault-Llorca, F.; Levrel, O.; Clémenson, A.; Kwiatkowski, F.; Pomel, C.; Fouilhoux, G.; De Latour, M.; Curé, H.; Déchelotte, P.; Fonck, Y.; Dauplat, J. 2000: Assessment of different histoprognosis grading systems for primary ovarian cancer: 100 patients given the same treatment for primary ovarian adenocarcinoma Journal de Gynecologie Obstetrique et Biologie de la Reproduction 29(6): 548-554
Walker, G.R.; Schlesselman, J.J.; Ness, R.B. 2002: Family history of cancer, oral contraceptive use, and ovarian cancer risk American Journal of Obstetrics and Gynecology 186(1): 8-14
Bit-Sava, E.M.; Belogurova, M.B.; Imianitov, E.N.; Balandov, S.G.; Korniushin, O.V.; Borisov, M.K. 2013: Methods of surgical prevention of breast cancer and of ovarian cancer in BRCA mutation carriers Voprosy Onkologii 59(2): 5-11